Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Risedronate (AN) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: risedronate
Brand name
(ARTG)
: RISEDRONATE AN risedronate sodium 30mg tablet blister packWhat this medicine is used for
(ARTG)
Treatment of Pagetãs disease of bone
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White to off-white coloured, circular shaped film coated biconvex tablets debossed with 'L' on one side and '30' on the other side
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 14 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient risedronate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Treatment – Bone Health
Treatment Diagnosed osteoporosis requires prescribed treatment to protect bone health
Read more on Healthy Bones Australia website
Osteoporosis treatment options - myDr.com.au
Osteoporosis treatment choices (including medicines and lifestyle measures) are based on your age, sex, general health, the severity of your osteoporosis and the likelihood of you breaking a bone.
Read more on MyDoctor website
Osteoporosis Treatment and Bone Health
Diagnosed osteoporosis requires prescribed treatment to protect bone health.
Read more on Healthy Bones Australia website
Top results
Risks and management for treating osteoporosis
Given the high prevalence of osteoporosis, many cases are likely to be undetected and undertreated.
Read more on Australian Prescriber website
Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016 - Australasian Menopause Society
Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated
Read more on Australasian Menopause Society website
Osteoporosis - Australasian Menopause Society
Osteoporosis is a condition characterised by weakened bones that fracture easily. After menopause many women are at risk of developing osteoporosis. Peak bone mass is usually reached during a woman’s 20s to 30s when the skeleton has stopped growing and bones are at their strongest. The female sex hormone oestrogen plays an important role in maintaining bone strength. After menopause oestrogen levels drop and this may result in increased bone loss. The average woman loses up to 10 per cent of
Read more on Australasian Menopause Society website